Terminated PHASE2 INTERVENTIONAL 1-arm NCT05091684

Administration of Fibrinogen Concentrate for Refractory Bleeding (FORMAT)

Administration of Fibrinogen Concentrate for Refractory Bleeding in Hematological Patients With Intensive Chemotherapy-induced Thrombocytopenia - Analysis Using Viscoelastic Haemostatic Assay (FORMAT)

Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Conditions Bleeding Hematological Patients Platelet Refractoriness

Interventions Fibrinogen Concentrate Human

Updated 11 times since 2021 Last updated: Dec 17, 2025 Started: Feb 10, 2022 Primary completion: May 25, 2023 Completion: Jun 27, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Only one patient was included in this study due to overly restrictive inclusion and exclusion criteria.

Other terminated trials from Centre Hospitalier Universitaire de Saint Etienne

See all terminations from Centre Hospitalier Universitaire de Saint Etienne

Other Bleeding trials with similar outcome

Browse all Bleeding trials

This PHASE2 trial investigates Bleeding and Hematological Patients and is currently terminated or withdrawn. Centre Hospitalier Universitaire de Saint Etienne leads this study, which shows 11 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE2

Status: Recruiting → Terminated
Sep 2025 — Jan 2026 [monthly]

Recruiting PHASE2
May 2025 — Sep 2025 [monthly]

Recruiting PHASE2
Nov 2024 — May 2025 [monthly]

Recruiting PHASE2
Sep 2024 — Nov 2024 [monthly]

Recruiting PHASE2

▶ Show 6 earlier versions

Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE2

Status: Active Not Recruiting → Recruiting
Jun 2023 — Apr 2024 [monthly]

Active Not Recruiting PHASE2

Status: Not Yet Recruiting → Active Not Recruiting
Mar 2022 — Jun 2023 [monthly]

Not Yet Recruiting PHASE2
Dec 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE2
Nov 2021 — Dec 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Data source: Centre Hospitalier Universitaire de Saint Etienne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint-Etienne, France